Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BBT-176 |
Synonyms | |
Therapy Description |
BBT-176 is a 4th generation EGFR inhibitor with enhanced activity against C797S-containing EGFR triple mutants, potentially leading to tumor growth inhibition (PMID: 37249619). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BBT-176 | BBT176|BBT 176 | EGFR Inhibitor 4th gen 16 | BBT-176 is a 4th generation EGFR inhibitor with enhanced activity against C797S-containing EGFR triple mutants, potentially leading to tumor growth inhibition (PMID: 37249619). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|